402 related articles for article (PubMed ID: 25500829)
1. 18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort.
Hatt M; Majdoub M; Vallières M; Tixier F; Le Rest CC; Groheux D; Hindié E; Martineau A; Pradier O; Hustinx R; Perdrisot R; Guillevin R; El Naqa I; Visvikis D
J Nucl Med; 2015 Jan; 56(1):38-44. PubMed ID: 25500829
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non-Small Cell Lung Cancer.
Tixier F; Vriens D; Cheze-Le Rest C; Hatt M; Disselhorst JA; Oyen WJ; de Geus-Oei LF; Visser EP; Visvikis D
J Nucl Med; 2016 Jul; 57(7):1033-9. PubMed ID: 26966161
[TBL] [Abstract][Full Text] [Related]
3. Visual versus quantitative assessment of intratumor 18F-FDG PET uptake heterogeneity: prognostic value in non-small cell lung cancer.
Tixier F; Hatt M; Valla C; Fleury V; Lamour C; Ezzouhri S; Ingrand P; Perdrisot R; Visvikis D; Le Rest CC
J Nucl Med; 2014 Aug; 55(8):1235-41. PubMed ID: 24904113
[TBL] [Abstract][Full Text] [Related]
4. Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?
Cook GJ; Yip C; Siddique M; Goh V; Chicklore S; Roy A; Marsden P; Ahmad S; Landau D
J Nucl Med; 2013 Jan; 54(1):19-26. PubMed ID: 23204495
[TBL] [Abstract][Full Text] [Related]
5. Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?
Groheux D; Majdoub M; Tixier F; Le Rest CC; Martineau A; Merlet P; Espié M; de Roquancourt A; Hindié E; Hatt M; Visvikis D
Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1682-1691. PubMed ID: 26140849
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional positron emission tomography image texture analysis of esophageal squamous cell carcinoma: relationship between tumor 18F-fluorodeoxyglucose uptake heterogeneity, maximum standardized uptake value, and tumor stage.
Dong X; Xing L; Wu P; Fu Z; Wan H; Li D; Yin Y; Sun X; Yu J
Nucl Med Commun; 2013 Jan; 34(1):40-6. PubMed ID: 23111378
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment 18F-FDG PET Textural Features in Locally Advanced Non-Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235.
Ohri N; Duan F; Snyder BS; Wei B; Machtay M; Alavi A; Siegel BA; Johnson DW; Bradley JD; DeNittis A; Werner-Wasik M; El Naqa I
J Nucl Med; 2016 Jun; 57(6):842-8. PubMed ID: 26912429
[TBL] [Abstract][Full Text] [Related]
8. Tumor texture analysis in 18F-FDG PET: relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysis.
Orlhac F; Soussan M; Maisonobe JA; Garcia CA; Vanderlinden B; Buvat I
J Nucl Med; 2014 Mar; 55(3):414-22. PubMed ID: 24549286
[TBL] [Abstract][Full Text] [Related]
9. Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?
Piñeiro-Fiel M; Moscoso A; Lado-Cacheiro L; Pombo-Pasín M; Rey-Bretal D; Gómez-Lado N; Mondelo-García C; Silva-Rodríguez J; Pubul V; Sánchez M; Ruibal Á; Aguiar P
Eur Radiol; 2021 Jun; 31(6):4156-4165. PubMed ID: 33247345
[TBL] [Abstract][Full Text] [Related]
10. Textural features and SUV-based variables assessed by dual time point 18F-FDG PET/CT in locally advanced breast cancer.
Garcia-Vicente AM; Molina D; Pérez-Beteta J; Amo-Salas M; Martínez-González A; Bueno G; Tello-Galán MJ; Soriano-Castrejón Á
Ann Nucl Med; 2017 Dec; 31(10):726-735. PubMed ID: 28887761
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
12. Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.
Werner RA; Kroiss M; Nakajo M; Mügge DO; Hahner S; Fassnacht M; Schirbel A; Bluemel C; Higuchi T; Papp L; Zsótér N; Buck AK; Bundschuh RA; Lapa C
Endocrine; 2016 Sep; 53(3):791-800. PubMed ID: 27138903
[TBL] [Abstract][Full Text] [Related]
13. Texture analysis of high-resolution dedicated breast
Moscoso A; Ruibal Á; Domínguez-Prado I; Fernández-Ferreiro A; Herranz M; Albaina L; Argibay S; Silva-Rodríguez J; Pardo-Montero J; Aguiar P
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):196-206. PubMed ID: 28936601
[TBL] [Abstract][Full Text] [Related]
14. Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.
Cheng NM; Fang YH; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Lin CY; Liao CT; Yen TC
J Nucl Med; 2013 Oct; 54(10):1703-9. PubMed ID: 24042030
[TBL] [Abstract][Full Text] [Related]
15. Textural Parameters of Tumor Heterogeneity in ¹⁸F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer.
Bundschuh RA; Dinges J; Neumann L; Seyfried M; Zsótér N; Papp L; Rosenberg R; Becker K; Astner ST; Henninger M; Herrmann K; Ziegler SI; Schwaiger M; Essler M
J Nucl Med; 2014 Jun; 55(6):891-7. PubMed ID: 24752672
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET.
Tixier F; Hatt M; Le Rest CC; Le Pogam A; Corcos L; Visvikis D
J Nucl Med; 2012 May; 53(5):693-700. PubMed ID: 22454484
[TBL] [Abstract][Full Text] [Related]
17.
Tsujikawa T; Rahman T; Yamamoto M; Yamada S; Tsuyoshi H; Kiyono Y; Kimura H; Yoshida Y; Okazawa H
Ann Nucl Med; 2017 Nov; 31(9):678-685. PubMed ID: 28815452
[TBL] [Abstract][Full Text] [Related]
18. Combining
Woff E; Kehagias P; Vandeputte C; Ameye L; Guiot T; Paesmans M; Hendlisz A; Flamen P
J Nucl Med; 2019 Oct; 60(10):1366-1372. PubMed ID: 30850494
[TBL] [Abstract][Full Text] [Related]
19. Impact of partial-volume effect correction on the predictive and prognostic value of baseline 18F-FDG PET images in esophageal cancer.
Hatt M; Le Pogam A; Visvikis D; Pradier O; Cheze Le Rest C
J Nucl Med; 2012 Jan; 53(1):12-20. PubMed ID: 22213819
[TBL] [Abstract][Full Text] [Related]
20. Repeatability of metabolically active tumor volume measurements with FDG PET/CT in advanced gastrointestinal malignancies: a multicenter study.
Frings V; van Velden FH; Velasquez LM; Hayes W; van de Ven PM; Hoekstra OS; Boellaard R
Radiology; 2014 Nov; 273(2):539-48. PubMed ID: 24865311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
